Abstract:In pharmaceutical research, understanding the biodistribution, accumulation and metabolism of drugs in tissue plays a key role during drug discovery and development. In particular, information regarding pharmacokinetics, pharmacodynamics and transport properties of compounds in tissues is crucial during early screening. Historically, the abundance and distribution of drugs have been assessed by well‐established techniques such as quantitative whole‐body autoradiography (WBA) or tissue homogenization with LC/MS analysis. However, WBA does not distinguish active drug from its metabolites and LC/MS, while highly sensitive, does not report spatial distribution. Mass spectrometry imaging (MSI) can discriminate drug and its metabolites and endogenous compounds, while simultaneously reporting their distribution. MSI data are influencing drug development and currently used in investigational studies in areas such as compound toxicity. In in vivo studies MSI results may soon be used to support new drug regulatory applications, although clinical trial MSI data will take longer to be validated for incorporation into submissions. We review the current and future applications of MSI, focussing on applications for drug discovery and development, with examples to highlight the impact of this promising technique in early drug screening. Recent sample preparation and analysis methods that enable effective MSI, including quantitative analysis of drugs from tissue sections will be summarized and key aspects of methodological protocols to increase the effectiveness of MSI analysis for previously undetectable targets addressed. These examples highlight how MSI has become a powerful tool in drug research and development and offers great potential in streamlining the drug discovery process.

Current Applications of Liquid Chromatography/Mass Spectrometry in Pharmaceutical Discovery After a Decade of Innovation

Pharmaceutical Applications of Liquid Chromatography Coupled with Mass Spectrometry (LC/MS)

State-of-the-art in liquid chromatography–mass spectrometry

Biochemical applications of mass spectrometry in pharmaceutical drug discovery

Open-access liquid chromatography/mass spectrometry in a drug discovery environment.

Applications of mass spectrometry in drug metabolism: 50 years of progress

A Review of Liquid Chromatography-Mass Spectrometry and its Applications in Chemical Analysis

Theory and Instrumentation of Mass Spectrometry and its Application to Drug Metabolism

Liquid-phase separations coupled with ion mobility-mass spectrometry for next-generation biopharmaceutical analysis

Multi‐dimensional technology – Recent advances and applications for biotherapeutic characterization

Recent Development in Liquid Chromatography/Mass Spectrometry and Emerging Technologies for Metabolite Identification

Ultra-high-throughput mass spectrometry in drug discovery: fundamentals and recent advances

Advances in high‐resolution mass spectrometry applied to pharmaceuticals in 2020: A whole new age of information

Recent advances in LC-MS based characterization of protein-based bio-therapeutics - mastering analytical challenges posed by the increasing format complexity

Advances in high‐throughput mass spectrometry in drug discovery

A Review on Liquid Chromatography-Tandem Mass Spectrometry Methods for Rapid Quantification of Oncology Drugs

Future technology insight: mass spectrometry imaging as a tool in drug research and development

It is time for a paradigm shift in drug discovery bioanalysis: from SRM to HRMS

The application and development of liquid chromatography-mass spectrometry in clinical laboratory medicine

Recent progress on the application of LC-MS-MS in drug metabolism

Small footprint liquid chromatography-mass spectrometry for pharmaceutical reaction monitoring and automated process analysis